AlphaCentric Advisors’s Insmed INSM Stock Holding History

AlphaCentric Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25M	Buy	11,699 +2,825	+32%	+$342K	1.06%	18
2026 Q1	$1.45M	Buy	8,874 +1,286	+17%	+$198K	1.45%	9
2025 Q4	$1.32M	Buy	+7,588	New	+$1.38M	1.32%	13
2024 Q4	$271K	Sell	3,930 -1,070	-21%	-$77.1K	0.27%	94
2024 Q3	$365K	Buy	+5,000	New	+$369K	0.27%	92
2023 Q4	–	Sell	-80,000	Closed	-$2.02M	–	261
2023 Q3	$2.02M	Sell	80,000 -15,000	-16%	-$343K	1.15%	27
2023 Q2	$2M	Buy	95,000 +10,500	+12%	+$199K	1.11%	24
2023 Q1	$1.44M	Buy	84,500 +64,500	+323%	+$1.25M	0.99%	26
2022 Q4	$400K	Buy	+20,000	New	+$387K	0.39%	82
2021 Q4	$776K	Hold	28,500	–	–	0.23%	44
2021 Q3	$785K	Buy	28,500 +4,500	+19%	+$118K	0.2%	44
2021 Q2	$683K	Buy	24,000 +22,900	+2,082%	+$680K	0.19%	42
2021 Q1	$37K	Hold	1,100	–	–	0.01%	202
2020 Q4	$37K	Buy	1,100 +447	+68%	+$16.3K	0.02%	194
2020 Q3	$21K	Buy	653 +353	+118%	+$10.1K	0.01%	145
2020 Q2	$8K	Buy	+300	New	+$7.11K	﹤0.01%	139

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AlphaCentric Advisors's INSM Position: Q2 2026 in Review

AlphaCentric Advisors increased its Insmed (INSM) stake by 32% in Q2 2026, buying an estimated $342K and bringing the position to 11,699 shares worth $1.25M. The position accounts for 1.06% of the portfolio, ranked #18.

AlphaCentric Advisors first reported a position in INSM in Q2 2020 and has held it in 16 quarters since. The position peaked at $2.02M in Q3 2023. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

AlphaCentric Advisors held 11,699 shares of Insmed worth $1.25M as of Q2 2026.
AlphaCentric Advisors bought 2,825 Insmed shares in Q2 2026, an estimated $342K.
Insmed made up 1.06% of AlphaCentric Advisors's portfolio in Q2 2026, its #18 holding.
AlphaCentric Advisors first reported a position in Insmed in Q2 2020 and has held it in 16 quarters since.
AlphaCentric Advisors's Insmed position peaked at $2.02M in Q3 2023.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.